Our group has previously reported that ASCs from human lipoaspirate from obese donors (BMI > 30) promote tumor growth and metastasis in ER+ breast cancer through, at least in part, a leptin-estrogen pathway [16, 17]. Here, LEP is linked to breast cancer.